Gene expression influences on metal immunomodulation

Toxicology and Applied Pharmacology

Volumn 210, Issue 1-2, 2006, Pages 9-16

  Lynes, Michael A ^a   Fontenot, Andrew P ^b   Lawrence, David A ^c   Rosenspire, Allen J ^d   Pollard, K Michael ^e  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c WADSWORTH CENTER   (United States)

^d WAYNE STATE UNIVERSITY   (United States)

^e SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Autoimmunity; Beryllium; Cytokine; Genetic checkpoints; Immunomodulation; Metallothionein; Metals; Signal transduction

Indexed keywords

BERYLLIUM; CYTOKINE; HEAVY METAL; LEAD; MERCURY; METALLOTHIONEIN;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; BERYLLIOSIS; CYTOKINE PRODUCTION; ENVIRONMENTAL EXPOSURE; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; HEAVY METAL POISONING; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOGENETICS; IMMUNOMODULATION; IMMUNOTOXICITY; LEAD POISONING; MAJOR HISTOCOMPATIBILITY COMPLEX; MERCURIALISM; NONHUMAN; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 29044437308     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2005.04.021     Document Type: Article

References (67)

1. A.B. Abdel-Mageed, and K.C. Agrawal Activation of nuclear factor kappaB: potential role in metallothionein-mediated mitogenic response Cancer Res. 58 1998 2335 2338
2. A. Armario, J. Hidalgo, J. Bas, C. Restrepo, A. Dingman, and J.S. Garvey Age-dependent effects of acute and chronic intermittent stresses on serum metallothionein Physiol. Behav. 39 1987 277 279
3. N. Beneton, P. Wolkenstein, M. Bagot, A. Cosnes, J. Wechsler, J.C. Roujeau, and J. Revuz Amicrobial pustulosis associated with autoimmune diseases: healing with zinc supplementation Br. J. Dermatol. 143 2000 1306 1310
4. L.A. Borghesi, and M.A. Lynes Stress proteins as agents of immunological change: some lessons from metallothionein Cell Stress Chaperones 1 1996 99 108
5. L.A. Borghesi, J. Youn, E.A. Olson, and M.A. Lynes Interactions of metallothionein with murine lymphocytes: plasma membrane binding and proliferation Toxicology 108 1996 129 140
6. E. Canpolat, and M.A. Lynes In vivo manipulation of endogenous metallothionein with a monoclonal antibody enhances a T-dependent humoral immune response Toxicol. Sci. 62 2001 61 70
7. K.C. Crowthers, V. Kline, C. Giardina, and M.A. Lynes Augmented humoral immune function in metallothionein-null mice Toxicol. Appl. Pharmacol. 166 2000 161 172
8. K.G. Danielson, S. Ohi, and P.C. Huang Immunochemical localization of metallothionein in rat liver and kidney J. Histochem. Cytochem. 30 1982 1033 1039
9. R. Dijkmans, H. Heremans, and A. Billiau Heterogeneity of Chinese hamster ovary cell-produced recombinant murine interferon-gamma J. Biol. Chem. 262 1987 2528 2535
10. H. El Refaey, M. Ebadi, C.A. Kuszynski, J. Sweeney, F.M. Hamada, and A. Hamed Identification of metallothionein receptors in human astrocytes Neurosci. Lett. 231 1997 131 134
11. C. Espejo, J. Carrasco, J. Hidalgo, M. Penkowa, A. Garcia, I. Saez-Torres, and E.M. Martinez-Caceres Differential expression of metallothioneins in the CNS of mice with experimental autoimmune encephalomyelitis Neuroscience 105 2001 1055 1065
12. A.P. Fontenot, and B.L. Kotzin Chronic beryllium disease: immune-mediated destruction with implications for organ-specific autoimmunity Tissue Antigens 62 2003 449 458
13. A.P. Fontenot, M.T. Falta, B.M. Freed, L.S. Newman, and B.L. Kotzin Identification of pathogenic T cells in patients with beryllium-induced lung disease J. Immunol. 163 1999 1019 1026
14. A.P. Fontenot, M. Torres, W.H. Marshall, L.S. Newman, and B.L. Kotzin Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease Proc. Natl. Acad. Sci. U.S.A. 97 2000 12717 12722
15. A.P. Fontenot, L.A. Maier, S.J. Canavera, T.B. Hendry-Hofer, M. Boguniewicz, E.A. Barker, L.S. Newman, and B.L. Kotzin Beryllium skin patch testing to analyze T cell stimulation and granulomatous inflammation in the lung J. Immunol. 168 2002 3627 3634
16. J. Gong, F.T. Liu, and S.S. Chen Polyphenolic antioxidants enhance IgE production Immunol. Invest. 33 2004 295 307
17. D.H. Hamer Metallothionein Annu. Rev. Biochem. 55 1986 913 951
18. Y. Heo, P.J. Parsons, and D.A. Lawrence Lead differentially modifies cytokine production in vitro and in vivo Toxicol. Appl. Pharmacol. 138 1996 149 157
19. Y. Heo, B.K. Lee, K.D. Ahn, and D.A. Lawrence Serum IgE elevation correlates with blood lead levels in battery manufacturing workers Hum. Exp. Toxicol. 23 2004 209 213
20. C.H. Kim, J.H. Kim, J. Lee, and Y.S. Ahn Zinc-induced NF-kappaB inhibition can be modulated by changes in the intracellular metallothionein level Toxicol. Appl. Pharmacol. 190 2003 189 196
21. M. Kowolenko, L. Tracy, and D.A. Lawrence Lead-induced alterations of in vitro bone marrow cell responses to colony stimulating factor-1 J. Leukocyte Biol. 45 1989 198 206
22. K. Kreiss, L.S. Newman, M.M. Mroz, and P.A. Campbell Screening blood test identifies subclinical beryllium disease J. Occup. Med. 31 1989 603 608
23. K. Kreiss, M.M. Mroz, B. Zhen, J.W. Martyny, and L.S. Newman Epidemiology of beryllium sensitization and disease in nuclear workers Am. Rev. Respir. Dis. 148 1993 985 991
24. K. Kreiss, S. Wasserman, M.M. Mroz, and L.S. Newman Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations J. Occup. Med. 35 1993 267 274
25. K. Kreiss, M.M. Mroz, L.S. Newman, J. Martyny, and B. Zhen Machining risk of beryllium disease and sensitization with median exposures below 2 micrograms/m3 Am. J. Ind. Med. 30 1996 16 25
26. W.T. Kwong, P. Friello, and R.D. Semba Interactions between iron deficiency and lead poisoning: epidemiology and pathogenesis Sci. Total Environ. 330 2004 21 37
27. D.A. Lawrence, and M.J. McCabe Immune modulation by toxic metals M. Waalkes R. Goyer C. Klaassen Organ-Specific Metal Toxicology 1995 Academic Press New York 305 337
28. M.J. Lenardo Molecular regulation of T lymphocyte homeostasis in the healthy and diseased immune system Immunol. Res. 27 2003 387 398
29. P.M. Lutz, T.J. Wilson, J. Ireland, A.L. Jones, J.S. Gorman, N.L. Gale, J.C. Johnson, and J.E. Hewett Elevated immunoglobulin E (IgE) levels in children with exposure to environmental lead Toxicology 134 1999 63 78
30. M.A. Lynes, J.S. Garvey, and D.A. Lawrence Extracellular metallothionein effects on lymphocyte activities Mol. Immunol. 27 1990 211 219
31. M.A. Lynes, C.A. Richardson, R. McCabe, K.C. Crowthers, J.C. Lee, J. Youn, I.B. Schweitzer, and L.D. Shultz Metallothionein-mediated alterations in autoimmune disease processes C. Klaassen Metallothionein IV 1999 Birkhauser Basel 437 444
32. B.L. Lyons, M.A. Lynes, L. Burzenski, M.J. Joliat, N. Hadjout, and L.D. Shultz Mechanisms of anemia in SHP-1 protein tyrosine phosphatase-deficient "viable motheaten" mice Exp. Hematol. 31 2003 234 243
33. L.A. Maier, D.S. McGrath, H. Sato, P. Lympany, K. Welsh, R. Du Bois, L. Silveira, A.P. Fontenot, R.T. Sawyer, E. Wilcox, and L.S. Newman Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease J. Immunol. 171 2003 6910 6918
34. M.J. McCabe Jr., and D.A. Lawrence The heavy metal lead exhibits B cell-stimulatory factor activity by enhancing B cell Ia expression and differentiation J. Immunol. 145 1990 671 677
35. M.J. McCabe Jr., M.J. Whitekus, J. Hyun, K.G. Eckles, G. McCollum, and A.J. Rosenspire Inorganic mercury attenuates CD95-mediated apoptosis by interfering with formation of the death inducing signaling complex Toxicol. Appl. Pharmacol. 190 2003 146 156
36. K.P. Mishra, V.K. Singh, R. Rani, V.S. Yadav, V. Chandran, S.P. Srivastava, and P.K. Seth Effect of lead exposure on the immune response of some occupationally exposed individuals Toxicology 188 2003 251 259
37. Y. Murata, M. Amao, J. Yoneda, and J. Hamuro Intracellular thiol redox status of macrophages directs the Th1 skewing in thioredoxin transgenic mice during aging Mol. Immunol. 38 2002 747 757
38. L.S. Newman, J. Lloyd, and E. Daniloff The natural history of beryllium sensitization and chronic beryllium disease Environ. Health Perspect. 104S 1996 937 943
39. M. Pande, and S.J. Flora Lead induced oxidative damage and its response to combined administration of alpha-lipoic acid and succimers in rats Toxicology 177 2002 187 196
40. M. Penkowa, and J. Hidalgo Metallothionein I+II expression and their role in experimental autoimmune encephalomyelitis Glia 32 2000 247 263
41. M. Penkowa, C. Espejo, A. Ortega-Aznar, J. Hidalgo, X. Montalban, and E.M. Martinez Caceres Metallothionein expression in the central nervous system of multiple sclerosis patients Cell. Mol. Life Sci. 60 2003 1258 1266
42. K.M. Pollard, and P. Hultman Effects of mercury on the immune system Met. Ions Biol. Syst. 34 1997 421 440
43. K.M. Pollard, D.L. Pearson, P. Hultman, T.N. Deane, U. Lindh, and D.H. Kono Xenobiotic acceleration of idiopathic systemic autoimmunity in lupus-prone bxsb mice Environ. Health Perspect. 109 2001 27 33
44. K.M. Pollard, P. Hultman, and D.H. Kono Using single-gene deletions to identify checkpoints in the progression of systemic autoimmunity Ann. N. Y. Acad. Sci. 987 2003 236 239
45. G.J. Prud'homme, D.H. Kono, and A.N. Theofilopoulos Quantitative polymerase chain reaction analysis reveals marked overexpression of interleukin-1 beta, interleukin-1 and interferon-gamma mRNA in the lymph nodes of lupus-prone mice Mol. Immunol. 32 1995 495 503
46. L. Richeldi, R. Sorrentino, and C. Saltini HLA-DPB1 glutamate 69: a genetic marker of beryllium disease Science 262 1993 242 244
47. L. Richeldi, K. Kreiss, M.M. Mroz, B. Zhen, P. Tartoni, and C. Saltini Interaction of genetic and exposure factors in the prevalence of berylliosis Am. J. Ind. Med. 32 1997 337 340
48. F. Rieux-Laucat, A. Fischer, and F.L. Deist Cell-death signaling and human disease Curr. Opin. Immunol. 15 2003 325 331
49. F. Rieux-Laucat, F. Le Deist, and A. Fischer Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways Cell Death Differ. 10 2003 124 133
50. P. Romagnoli, A.M. Labhardt, and F. Sinigaglia Selective interaction of Ni with an MHC-bound peptide EMBO J. 10 1991 1303 1306
51. M.D. Rossman, J. Stubbs, C.W. Lee, E. Argyris, E. Magira, and D. Monos Human leukocyte antigen Class II amino acid epitopes: susceptibility and progression markers for beryllium hypersensitivity Am. J. Respir. Crit. Care Med. 165 2002 788 794
52. A. Sakurai, S. Hara, N. Okano, Y. Kondo, J. Inoue, and N. Imura Regulatory role of metallothionein in NF-kappaB activation FEBS Lett. 455 1999 55 58
53. L.D. Shultz, T.V. Rajan, and D.L. Greiner Severe defects in immunity and hematopoiesis caused by SHP-1 protein-tyrosine-phosphatase deficiency Trends Biotechnol. 15 1997 302 307
54. R.M. Siegel, J.K. Frederiksen, D.A. Zacharias, F.K. Chan, M. Johnson, D. Lynch, R.Y. Tsien, and M.J. Lenardo Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations Science 288 2000 2354 2357
55. C.O. Simpkins Metallothionein in human disease Cell. Mol. Biol. (Noisy-le-grand) 46 2000 465 488
56. J.E. Snyder, N.M. Filipov, P.J. Parsons, and D.A. Lawrence The efficiency of maternal transfer of lead and its influence on plasma IgE and splenic cellularity of mice Toxicol. Sci. 57 2000 87 94
57. J.A. Snyder, A. Weston, S.S. Tinkle, and E. Demchuk Electrostatic potential on human leukocyte antigen: implications for putative mechanism of chronic beryllium disease Environ. Health Perspect. 111 2003 1827 1834
58. L.R. Sun, and J.B. Suszkiw Extracellular inhibition and intracellular enhancement of Ca2+ currents by Pb2+ in bovine adrenal chromaffin cells J. Neurophysiol. 74 1995 574 581
59. L. Tian, and D.A. Lawrence Lead inhibits nitric oxide production in vitro by murine splenic macrophages Toxicol. Appl. Pharmacol. 132 1995 156 163
60. Z. Wang, P.S. White, M. Petrovic, O.L. Tatum, L.S. Newman, L.A. Maier, and B.L. Marrone Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles J. Immunol. 163 1999 1647 1653
61. M.J. Whitekus, R.P. Santini, A.J. Rosenspire, and M.J. McCabe Jr. Protection against CD95-mediated apoptosis by inorganic mercury in Jurkat T cells J. Immunol. 162 1999 7162 7170
62. Z. Wu, I.A. MacPhee, and D.B. Oliveira Reactive oxygen species in the initiation of IL-4 driven autoimmunity as a potential therapeutic target Curr. Pharm. Des. 10 2004 899 913
63. J. Youn, and M.A. Lynes Metallothionein-induced suppression of cytotoxic T lymphocyte function: an important immunoregulatory control Toxicol. Sci. 52 1999 199 208
64. J. Youn, S.H. Hwang, Z.Y. Ryoo, M.A. Lynes, D.J. Paik, H.S. Chung, and H.Y. Kim Metallothionein suppresses collagen-induced arthritis via induction of TGF-beta and down-regulation of proinflammatory mediators Clin. Exp. Immunol. 129 2002 232 239
65. B. Yucesoy, A. Turhan, M. Ure, T. Imir, and A. Karakaya Effects of occupational lead and cadmium exposure on some immunoregulatory cytokine levels in man Toxicology 123 1997 143 147
66. E.J. Yurkow, and C.J. DeCoste Effects of cadmium on metallothionein levels in human peripheral blood leukocytes: a comparison with zinc J. Toxicol. Environ. Health, A 58 1999 313 327
67. E.J. Yurkow, and P.R. Makhijani Flow cytometric determination of metallothionein levels in human peripheral blood lymphocytes: utility in environmental exposure assessment J. Toxicol. Environ. Health, A 54 1998 445 457